Vimta Labs P/E Ratio
Vimta Labs (VIMTALABS) P/E ratio is 35.09 (High), EPS (TTM) ₹18.51, current price ₹603.10 on NSE vs historical average P/E of 8.62 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see VIMTALABS stock price BSE.
Current Valuation Metrics
Valuation Signal
Sector Context
Earnings Breakdown (TTM)
VIMTALABS P/E Ratio — Valuation Signal & Historical Context
Vimta Labs P/E 35.09 vs historical average 8.62, range 5.16–12.24 — signal: Overvalued. Also explore VIMTALABS share price charts to track price trends across different timeframes.
- Stock appears overvalued with PE of 35.09, suggesting caution for new investments
- Current PE is 307.0% above historical average
- Trading at discount to sector average PE of 56.61
Vimta Labs P/E Ratio Historical Trend
VIMTALABS annual price-to-earnings ratio — 4 years, EPS and year-end price. Current P/E 35.09 vs historical average 8.62.
VIMTALABS Historical P/E Ratio — EPS, Year-End Price & Valuation
Vimta Labs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.
| Year | P/E Ratio | EPS (₹) | Year-end Price (₹) | Exchange | Valuation |
|---|---|---|---|---|---|
| 2024 | 7.33 | 27.65 | ₹202.65 | NSE | Low |
| 2023 | 12.24 | 17.71 | ₹216.85 | NSE | Low |
| 2022 | 9.76 | 21.4 | ₹208.85 | NSE | Low |
| 2021 | 5.16 | 16.84 | ₹86.95 | NSE | Low |
VIMTALABS vs Healthcare Peers — P/E Ratio Comparison
Vimta Labs P/E 35.09 vs Healthcare average 56.61, median 31.27 — range 1.99–747.21.
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.21 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.45 | ₹60 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.01 | ₹45 | Low |